Novartis Should Be Bought On A Pullback

Novartis (NYSE:NVS) Should Be Bought On A Pullback. Entresto & Cosentyx drugs really have the ability to drive sales forward.

This entry was posted in Novartis and tagged . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *